Selective tyrosine kinase inhibitor for the platelet-derived growth factor receptor in vitro inhibits smooth muscle cell proliferation after reinjury of arterial intima in vivo - PubMed (original) (raw)
Selective tyrosine kinase inhibitor for the platelet-derived growth factor receptor in vitro inhibits smooth muscle cell proliferation after reinjury of arterial intima in vivo
M Myllärniemi et al. Cardiovasc Drugs Ther. 1999 Apr.
Abstract
The long-term success of coronary angioplasty is limited by restonosis. This study was undertaken to investigate whether and to what extent the enhanced proliferative response observed in a balloon reinjury model of rat aorta is regulated by the PDGF receptor (PDGF-R). Balloon injury was performed to 14-day-old pre-existing neointimal lesion in rat aorta. PDGF receptor and ligand immunoreactivity were measured at several time points after the first and second injury, and PDGF-R signaling was blocked with a selective inhibitor of PDGF-R tyrosine kinase. In the neointima, after repeated injury, upregulation of PDGF-AA was seen to coincide with a prompt proliferative response of smooth muscle cells (SMC). Administration of the PDGF-R tyrosine kinase inhibitor in vivo, tested and found to inhibit the proliferation of SMC induced by PDGF-AA and PDGF-BB, but not by IGF-1, EGF, or bFGF, resulted in a 60% reduction in the absolute number and percentage of BrdU + cells after the second balloon injury to pre-existing neointima, but had no significant effect on proliferation after the first injury. Endpoint lesion area was reduced by 50% in the treated group at 14 days after the second injury. The results suggest that systemic administration of a tyrosine kinase inhibitor specific for the PDGF-R can be useful in the prevention of restenosis.
Similar articles
- PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine.
Banai S, Wolf Y, Golomb G, Pearle A, Waltenberger J, Fishbein I, Schneider A, Gazit A, Perez L, Huber R, Lazarovichi G, Rabinovich L, Levitzki A, Gertz SD. Banai S, et al. Circulation. 1998 May 19;97(19):1960-9. doi: 10.1161/01.cir.97.19.1960. Circulation. 1998. PMID: 9609090 - Imatinib mesilate inhibits neointimal hyperplasia via growth inhibition of vascular smooth muscle cells in a rat model of balloon injury.
Makiyama Y, Toba K, Kato K, Hirono S, Ozawa T, Saigawa T, Minagawa S, Isoda M, Asami F, Ikarashi N, Oda M, Moriyama M, Higashimura M, Kitajima T, Otaki K, Aizawa Y. Makiyama Y, et al. Tohoku J Exp Med. 2008 Aug;215(4):299-306. doi: 10.1620/tjem.215.299. Tohoku J Exp Med. 2008. PMID: 18679003 - Inhibition of platelet-derived growth factor receptor tyrosine kinase inhibits vascular smooth muscle cell migration and proliferation.
Myllärniemi M, Calderon L, Lemström K, Buchdunger E, Häyry P. Myllärniemi M, et al. FASEB J. 1997 Nov;11(13):1119-26. doi: 10.1096/fasebj.11.13.9367346. FASEB J. 1997. PMID: 9367346 - Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation.
Nykänen AI, Krebs R, Tikkanen JM, Raisky O, Sihvola R, Wood J, Koskinen PK, Lemström KB. Nykänen AI, et al. Transplantation. 2005 Jan 27;79(2):182-9. doi: 10.1097/01.tp.0000147199.60464.f9. Transplantation. 2005. PMID: 15665766 - [Imatinib mesylate as a novel therapeutic drug for systemic rheumatic diseases].
Kameda H. Kameda H. Nihon Rinsho Meneki Gakkai Kaishi. 2007 Jun;30(3):165-73. doi: 10.2177/jsci.30.165. Nihon Rinsho Meneki Gakkai Kaishi. 2007. PMID: 17603257 Review. Japanese.
Cited by
- Inhibition of vascular smooth muscle cell proliferation by Gentiana lutea root extracts.
Kesavan R, Potunuru UR, Nastasijević B, T A, Joksić G, Dixit M. Kesavan R, et al. PLoS One. 2013 Apr 18;8(4):e61393. doi: 10.1371/journal.pone.0061393. Print 2013. PLoS One. 2013. PMID: 23637826 Free PMC article. - Constitutive ALK5-independent c-Jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: evidence of an autocrine endothelin loop operating through the endothelin A and B receptors.
Shi-Wen X, Rodríguez-Pascual F, Lamas S, Holmes A, Howat S, Pearson JD, Dashwood MR, du Bois RM, Denton CP, Black CM, Abraham DJ, Leask A. Shi-Wen X, et al. Mol Cell Biol. 2006 Jul;26(14):5518-27. doi: 10.1128/MCB.00625-06. Mol Cell Biol. 2006. PMID: 16809784 Free PMC article. - Induction of immune tolerance by activation of CD8+ T suppressor/regulatory cells in lupus-prone mice.
Skaggs BJ, Singh RP, Hahn BH. Skaggs BJ, et al. Hum Immunol. 2008 Nov;69(11):790-6. doi: 10.1016/j.humimm.2008.08.284. Epub 2008 Sep 24. Hum Immunol. 2008. PMID: 18817829 Free PMC article. Review. - Neointimal hyperplasia associated with synthetic hemodialysis grafts.
Li L, Terry CM, Shiu YT, Cheung AK. Li L, et al. Kidney Int. 2008 Nov;74(10):1247-61. doi: 10.1038/ki.2008.318. Epub 2008 Jul 30. Kidney Int. 2008. PMID: 18668026 Free PMC article. Review. - Copper chelation represses the vascular response to injury.
Mandinov L, Mandinova A, Kyurkchiev S, Kyurkchiev D, Kehayov I, Kolev V, Soldi R, Bagala C, de Muinck ED, Lindner V, Post MJ, Simons M, Bellum S, Prudovsky I, Maciag T. Mandinov L, et al. Proc Natl Acad Sci U S A. 2003 May 27;100(11):6700-5. doi: 10.1073/pnas.1231994100. Epub 2003 May 16. Proc Natl Acad Sci U S A. 2003. PMID: 12754378 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous